Aadi Bioscience investor relations material
Listen to the latest call from Aadi Bioscience
Aadi Bioscience, Inc. is a clinical stage biopharmaceutical company engaged in the development and commercialization of precision therapies for genetically defined cancers with alterations in mTOR pathway genes. The company develops products designed to treat patients whose cancer can be targeted by specific genetic abnormalities. It focuses on small molecule drugs that utilize bispecific antibody formats as a method of highly targeted cancer therapy. The company was founded in 2007 and is headquartered in Pacific Palisades, California.